Weiwei Shan

ORCID: 0000-0001-6729-2683 · 6 papers in corpus
diagnostic-accuracy 2026
Cell reports. Medicine ·doi:10.1016/j.xcrm.2026.102805

Endometrial cancer (EC) incidence is rising, yet current diagnostics lack precision and scalability. We develop an artificial intelligence (AI)-based platform integrating multi-biofluid omics and clinical data for EC stratification. Using t…

case-report 2025
Frontiers in oncology ·doi:10.3389/fonc.2025.1572914

INTRODUCTION: Low-grade endometrial stromal sarcoma (LGESS) is a rare malignant tumor of the uterus, characterized by slow growth. Early-stage LGESS is associated with favorable survival, but it has a high recurrence rate. The primary treat…

lab-animal 2023
·doi:10.6084/m9.figshare.23354524

Additional file 9. Raw data of cell viability experiments.

rct 2023
Gynecologic Oncology ·doi:10.1016/j.ygyno.2023.05.001

OBJECTIVE: To compare the effects of levonorgestrel-intrauterine system (LNG-IUS) with or without oral megestrol acetate (MA) versus MA alone on fertility-preserving treatment in patients with atypical endometrial hyperplasia (AEH). METHOD…

2023
·doi:10.1136/ijgc-2023-igcs.18
lab-animal 2012
Cell cycle (Georgetown, Tex.) ·doi:10.4161/cc.20544

Recent studies have suggested that some ovarian and pelvic serous carcinomas could originate from the fimbriated end of the distal fallopian tube. To test this hypothesis, we immortalized a normal human fallopian tube epithelial (FTE) cell …